| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/07/2006 | US6995002 Nucleotide sequences which code for the mdhA gene |
| 02/07/2006 | US6995000 Nucleotide sequences coding for the sigM gene |
| 02/07/2006 | US6994999 Isolated DNA molecule comprising the promoter sequence of a bovine myostatin gene |
| 02/07/2006 | US6994998 substituting a base-modified nucleotide that renders the polynucleotide more susceptible to cleavage at the sites of its incorporation for a natural nucleotide in a polynucleotide; 1-ribose-4-amino-5-hydroxy-1,2-dihydropyrimidin-2-one for example |
| 02/07/2006 | US6994997 Gram positive bacteria deprived of HtrA protease activity and their uses |
| 02/07/2006 | US6994996 polypeptide able to regulate ATPase activity; use treating various disease such as malignant tumors, hemopathies, HIV infections, immune diseases and inflammations |
| 02/07/2006 | US6994994 Of the tumor necrosis factor receptor family; given amino acid sequence; use treating diseases and disorders ameliorated or cured by decreasing the levels of ligands of the original CD40R such as autoimmune diseases |
| 02/07/2006 | US6994993 Nucleotide sequences coding membrane protein for use inthe treatment of epilepsey, arrhythmia, and pain in humans |
| 02/07/2006 | US6994991 Identification of differentially methylated multiple drug resistance loci |
| 02/07/2006 | US6994990 Active modified hedgehog proteins |
| 02/07/2006 | US6994989 Fetal liver kinase 1 (flk-1), is a member of the type III subclass of receptor tyrosine kinase (RTK) family; specified amino acid and nucleotide sequences; expression vectors; expression by a host cell; modulators of angiogenesis |
| 02/07/2006 | US6994982 Isolating biological modulators from biodiverse gene fragment libraries |
| 02/07/2006 | US6994978 Human osteoclast derived cathepsin |
| 02/07/2006 | US6994977 Combining a compound to be tested, a host cell expressing a recombinant protein containing a mammalian C-C chemokine receptor 3 and a ligand for binding of ligand to such receptor, detecting the formation of a receptor-ligand complex |
| 02/07/2006 | US6994975 Expression and purification of ATM protein using vaccinia virus |
| 02/07/2006 | US6994974 Drug screening for a substance that inhibits endoplasmic reticulum associated amyloid-beta peptide binding (ERAB) polypeptide from binding to amyloid-beta peptide; neurodegenerative disorders |
| 02/07/2006 | US6994965 Visual comfirmation of similarity score calculated from base sequences of probe biopolymers represented by, e.g., square patterns having varying depths in color; accuracy; side by side display for comparison; unexpected hybridization; microarrays |
| 02/07/2006 | US6994964 Macromolecular arrays on polymeric brushes and methods for preparing the same |
| 02/07/2006 | US6994963 Methods for recombinatorial nucleic acid synthesis |
| 02/07/2006 | US6994960 Detecting a mutation between a nucleic acid molecule to be tested and a reference nucleic acid molecule by base specific cleavage followed by Matrix-Assisted Laser Desorption/Ionization MS; does it require a gel electrophoresis step |
| 02/07/2006 | US6994959 which compete with DNA-binding sites of regulatory proteins which regulate t-cell activity (CD28 and cytokines), preventing transcription; analyzing immunocompetence; for treatment of autoimmune diseases |
| 02/07/2006 | US6994957 Using nucleic acid |
| 02/07/2006 | US6994882 A Brassica seed oil, having a stearic acid content of about 15% to about 30% and a polyunsaturated fatty acid content of about 2% to about 15% |
| 02/07/2006 | US6994860 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 02/07/2006 | US6994858 Infecting the mixed cellular compositions with reovirus which selectively lyse the ras-mediated neoplastic cells in the mixed composition |
| 02/07/2006 | US6994857 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 02/07/2006 | US6994854 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections |
| 02/07/2006 | CA2414471C Methods for enhancing plant transformation frequencies |
| 02/07/2006 | CA2369057C Methods of using viral replicase polynucleotides and polypeptides |
| 02/07/2006 | CA2207264C Reversible nuclear genetic system for male sterility in transgenic plants |
| 02/07/2006 | CA1341494C Plants with modified stamen cells |
| 02/06/2006 | CA2511314A1 Novel recombinant t4 phage particle and uses thereof |
| 02/02/2006 | WO2006012646A2 Amacr cancer markers |
| 02/02/2006 | WO2006012594A2 Modification of lignin biosynthesis |
| 02/02/2006 | WO2006012451A2 Compositions and methods of use for mgd-csf in disease treatment |
| 02/02/2006 | WO2006012414A2 Novel polyadenylation signal for use in expression vectors |
| 02/02/2006 | WO2006012393A2 Addition of transgenes into adenoviral vectors |
| 02/02/2006 | WO2006012326A1 Delta-8 desaturase and its use in making polyunsaturated fatty acids |
| 02/02/2006 | WO2006012325A1 Delta-8 desaturase and its use in making polyunsaturated fatty acids |
| 02/02/2006 | WO2006012309A1 Inducible inactivation of synaptic transmission |
| 02/02/2006 | WO2006012221A2 Target cell-specific short interfering rna and methods of use thereof |
| 02/02/2006 | WO2006012080A2 Microbial glyphosate resistant 5-enolpyruvylshikimate-3-phosphate synthases |
| 02/02/2006 | WO2006012024A2 Cell number polynucleotides and polypeptides and methods of use thereof |
| 02/02/2006 | WO2006011959A1 Method for agrobacterium transformation for dohaploid corn plants |
| 02/02/2006 | WO2006011795A2 Method for preventing dehiscence and altering plant lignification |
| 02/02/2006 | WO2006011678A1 Hybridization apparatus and hybridization method |
| 02/02/2006 | WO2006011667A1 METHOD OF MEASURING HETEROGENOUS NCULEAR NIBONUCLEOPROTEIN B1 (hnRNP B1) mRNA |
| 02/02/2006 | WO2006011589A1 Method of preparing artificial gene population and artificial protein population by random polymerization of motif sequences of multiple types |
| 02/02/2006 | WO2006011491A1 Plasmid vector, transgenic animal, method of screening drug and drug |
| 02/02/2006 | WO2006010930A2 Enzymes |
| 02/02/2006 | WO2006010834A1 Non-integrative and non-replicative lentivirus, preparation and uses thereof |
| 02/02/2006 | WO2006010634A1 Chn-1/chip-antagonists for the treatment of muscular diseases |
| 02/02/2006 | WO2006001023A3 Chimeric proteins and uses thereof |
| 02/02/2006 | WO2005120222A3 Genetically modified non-human mammals and cells |
| 02/02/2006 | WO2005118806A9 METHODS AND COMPOSITIONS INVOLVING MicroRNA |
| 02/02/2006 | WO2005117989A9 Drugs for the prevention or treatment of immunodeficiencies, autoimmune diseases or for the induction of immune tolerance |
| 02/02/2006 | WO2005105833A3 Novel herpes simplex viruses and uses thereof |
| 02/02/2006 | WO2005102033A3 Instrument for delivery of optical energy to the dental root canal system for hidden bacterial and live biofilm thermolysis |
| 02/02/2006 | WO2005097992A3 Modified polynucleotides for reducing off-target effects in rna interference |
| 02/02/2006 | WO2005094899A8 Clusterin antisense therapy for treatment of cancer |
| 02/02/2006 | WO2005087934A3 Barley for production of flavor-stable beverage |
| 02/02/2006 | WO2005074560A3 Compositions and methods that enhance rna interference |
| 02/02/2006 | WO2005068639A3 Particle-induced ghrelin immune response |
| 02/02/2006 | WO2005035759A8 RNA INTERFERENCE MEDIATED INHIBITION OF HYPOXIA INDUCIBLE FACTOR 1 (HIF1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 02/02/2006 | WO2005035752A3 Materials and methods for synthesis of a flavor and aroma volatile in plants |
| 02/02/2006 | WO2005032486A3 A NOVEL SIRNA-BASED APPROACH TO TARGET THE HIF-α FACTOR FOR GENE THERAPY |
| 02/02/2006 | WO2005021581A3 Inducers of plant disease resistance |
| 02/02/2006 | WO2005014775A3 Raav compositions and methods for delivery of human factor vii polypeptides and treatment of hemophilia a |
| 02/02/2006 | WO2005001039A3 Ribozyme-regulated small inhibitory rna (sirna) production and methods of use thereof |
| 02/02/2006 | WO2004113867A3 Exon analysis |
| 02/02/2006 | WO2004101755A3 Ref1 modified plants and plant seeds |
| 02/02/2006 | WO2004101753A3 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts |
| 02/02/2006 | WO2004100877A3 Vaccine accelerator factor (vaf) for poultry |
| 02/02/2006 | WO2004097004A3 Trasngenic expression of a phytochrome a gene |
| 02/02/2006 | WO2004083454A8 Wheel motion control input device for animation system |
| 02/02/2006 | WO2004058940A3 Sirna-mediated gene silencing |
| 02/02/2006 | WO2004012669A3 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides |
| 02/02/2006 | WO2003102166A3 Novel flavivirus antigens |
| 02/02/2006 | WO2002094990A3 Receptors and membrane-associated proteins |
| 02/02/2006 | US20060026721 Plant cellulose synthases |
| 02/02/2006 | US20060026720 Plant proteins |
| 02/02/2006 | US20060026719 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby |
| 02/02/2006 | US20060026718 Method of controlling cellular processes in plants |
| 02/02/2006 | US20060026717 nucleotide sequences or fragments, used for expressing heterologous proteins to the embryo tissue of monocotyledonous plants particularly cereals and corn |
| 02/02/2006 | US20060026716 Transcriptional activators involved in abiotic stress tolerance |
| 02/02/2006 | US20060026715 Commercial production of polysaccharide degrading enzymes in plants and methods of using same |
| 02/02/2006 | US20060026714 High oleic high stearic plants, seeds and oils |
| 02/02/2006 | US20060026713 Nucleotide sequences coding beta ketoacyl-acyl carrier protein synthase II for use in modifying fatty acid concentration in crop plants |
| 02/02/2006 | US20060026712 Method for the generation of green-note compounds |
| 02/02/2006 | US20060026711 Non-systemic gene suppression in plants |
| 02/02/2006 | US20060026710 Methods of protecting plants from pathogenic fungi |
| 02/02/2006 | US20060026709 Methods of protecting plants from pathogenic fungi |
| 02/02/2006 | US20060026708 Meloidogyne incognita, fusarium oxysporum and/or verticillium dahliae resistant plant; disease resistant crops |
| 02/02/2006 | US20060026707 Isolated from Zea mays; transformed plant; can be used to repress the expression of a desired target gene in specific plant tissue or to prevent the repression of a particular desired target gene |
| 02/02/2006 | US20060026706 Method for marker-less integration of a sequence of interest into the genome of a cell |
| 02/02/2006 | US20060026705 Plant amino acid biosynthetic enzymes |
| 02/02/2006 | US20060026704 Vector for the production of transplastomic angiosperm plants |
| 02/02/2006 | US20060026701 Human albumin animal models for drug evaluation, Toxicology and immunogenicity studies |
| 02/02/2006 | US20060026700 Tissue specific genes and gene clusters |
| 02/02/2006 | US20060026698 Transgenic transchromosomal rodents for making human antibodies |